Hematological Markers in Children and Adults with Atopic Dermatitis: A Retrospective Cohort Study
Dermatology · 2024
DOI: 10.1159/000539365 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift Dermatology, 2024. Verfasst von Sarah Weissmann und 4 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel, grzebins@post.bgu.ac.il. Hauptthemen laut MEDLINE: Dermatitis, Atopic, Severity of Illness Index, Biomarkers. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 25 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Introduction
Atopic dermatitis (AD) is a common chronic skin disease with an inflammatory pathophysiology that includes the activation of the innate and adaptive immune systems. We aimed to investigate the neutrophil-to-lymphocyte ratio (NLR), platelet-to-lymphocyte ratio (PLR), eosinophil-to-lymphocyte ratio (ELR), and eosinophil-to-neutrophil ratio (ENR) in AD patients, according to age and disease severity.
Methods
This is a retrospective, population-based cohort study conducted between the years 2005 and 2020, comparing hematological markers of AD patients and sex-age-ethnicity-matched controls. AD patients were further divided by age and disease severity (mild, moderate-to-severe AD). We created a decision tree to predict moderate-severe AD.
Results
A total of 13,928 patients with AD were included in this study: 6,828 adults and 7,100 children, with 13,548 controls. NLR, PLR, and ELR were lower in children compared to adults (p values <0.001). NLR, PLR, ELR, and ENR were increased in moderate-severe AD patients compared to mild AD patients (p values <0.001). PLR, ELR, and ENR were increased in AD patients versus controls (p values <0.001), with an additional increase in the NLR of moderate-to-severe AD patients. Patients with an ELR <0.21, a PLR >161, and ENR ≤0.016 should be considered high risk for developing severe AD, as well as patients with an ELR >0.21 and age at diagnosis <30 or age >30 years and mean platelet volume ≤9.
Conclusion
Hematological ratios were significantly higher in moderate-to-severe AD patients, compared to mild AD patients. Hematological markers were lower in children with AD compared to adults, except for ENR, likely reflecting age-related changes in blood count parameters. These markers can assist in the management and follow-up of AD patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel, grzebins@post.bgu.ac.il.
- Clinical Research Unit, Soroka University Medical Center, Beer Sheva, Israel, grzebins@post.bgu.ac.il.
- Clinical Research Unit, Soroka University Medical Center, Beer Sheva, Israel.
- Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel.
- Pediatric Pulmonary Unit, Soroka University Medical Center, Beer Sheva, Israel.
- Pediatric Dermatology Service, Soroka University Medical Center, Beer Sheva, Israel.
Zitieren
APA
Weissmann, S., Babyev, A. S., Gordon, M., Golan-Tripto, I., & Horev, A. (2024). Hematological Markers in Children and Adults with Atopic Dermatitis: A Retrospective Cohort Study. Dermatology. https://doi.org/10.1159/000539365
Vancouver
Weissmann S, Babyev AS, Gordon M, Golan-Tripto I, Horev A. Hematological Markers in Children and Adults with Atopic Dermatitis: A Retrospective Cohort Study. Dermatology. 2024. doi:10.1159/000539365
BibTeX
@article{Weissmann2024,
author = {Weissmann, Sarah and Babyev, Amit Shira and Gordon, Michal and Golan-Tripto, Inbal and Horev, Amir},
title = {Hematological Markers in Children and Adults with Atopic Dermatitis: A Retrospective Cohort Study},
journal = {Dermatology},
year = {2024},
doi = {10.1159/000539365}
}
EUVIMED